Skip to main content

Advertisement

SpringerLink
Log in

The association between breast cancer and thyroid cancer: a meta-analysis

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Previous studies have suggested an association between breast cancer and thyroid cancer; however, there has not been a formal meta-analysis which collates the existing evidence supporting the hypothesis that breast cancer or thyroid cancer predisposes an individual to developing the other. A systematic search was carried out using PubMed and Medline. We searched for articles containing epidemiological evidence of breast cancer following thyroid cancer and vice versa. Additionally, we searched for articles that included epidemiological data involving the incidence of all second primary malignancies (SPMs) following both breast cancer and thyroid cancer, and compared the datasets. The meta-analysis performed in a total of 18 studies showed that there is a significantly increased risk of developing thyroid cancer as a second primary malignancy of breast cancer (SIR = 1.59, 95 % confidence interval (CI) 1.28–1.99). Additionally, there was marginally increased risk of developing breast cancer as a second primary malignancy of thyroid cancer (SIR = 1.24, 95 % CI 1.16–1.33), compared to the general risk of developing a second primary malignancy following thyroid cancer. The findings suggest that the risk of developing thyroid cancer as a second primary malignancy of breast cancer and vice versa is increased compared to the background risk of developing other SPMs. The risk of developing thyroid cancer after a primary breast cancer was higher than the risk of developing breast cancer as a second primary malignancy of thyroid cancer. This suggests that the effects of treatment-related factors and specific pathological processes of each cancer may contribute to the increased risk rather than common risk factors including genetic factors. Elucidation of the common mechanisms between breast cancer and thyroid cancer will have important implications in both diagnostic and therapeutic management of these cancers. Benefit of thyroid ultrasound screening after breast cancer surgery needs to be assessed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Chalstrey LJ, Benjamin B (1966) High incidence of breast cancer in thyroid cancer patients. Br J Cancer 20(4):670–675

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ron E et al (1984) Multiple primary breast and thyroid cancer. Br J Cancer 49(1):87–92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Davies L, Welch H (2006) Increasing incidence of thyroid cancer in the united states, 1973–2002. JAMA 295(18):2164–2167

    Article  CAS  PubMed  Google Scholar 

  4. Xu F et al (2009) Diagnosis and therapy of childhood thyroid carcinoma: clinical analysis of 12 cases. Zhongguo Dang Dai Er Ke Za Zhi 11(2):120–123

    PubMed  Google Scholar 

  5. Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91(1):4–15 Discussion 1–3

    Article  PubMed  Google Scholar 

  6. Yu J et al (2009) Fine-needle aspiration of breast carcinoma metastatic to follicular variant of papillary thyroid carcinoma. Diagn Cytopathol 37(9):665–666

    Article  PubMed  Google Scholar 

  7. Robison LL (2009) Treatment-associated subsequent neoplasms among long-term survivors of childhood cancer: the experience of the Childhood Cancer Survivor Study. Pediatr Radiol 39(Suppl 1):S32–S37

    Article  PubMed  Google Scholar 

  8. Ronckers CM, McCarron P, Ron E (2005) Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 117(2):281–288

    Article  CAS  PubMed  Google Scholar 

  9. Harvey EB, Brinton LA (1985) Second cancer following cancer of the breast in Connecticut, 1935–82. Natl Cancer Inst Monogr 68:99–112

    CAS  PubMed  Google Scholar 

  10. McTiernan A, Weiss NS, Daling JR (1987) Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res 47(1):292–295

    CAS  PubMed  Google Scholar 

  11. Murakami R et al (1987) Second primary cancers following female breast cancer in Osaka, Japan—a population-based cohort study. Jpn J Clin Oncol 17(4):293–302

    PubMed  Google Scholar 

  12. Hrafnkelsson J et al (1989) Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours. Acta Oncol 28(6):785–788

    Article  CAS  PubMed  Google Scholar 

  13. Stein M et al (1989) Multiple primary thyroid and breast cancer in Israel, 1960–1976. S Afr Med J 76(12):664–666

    CAS  PubMed  Google Scholar 

  14. Volk N, Pompe-Kirn V (1997) Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 8(5):764–770

    Article  CAS  PubMed  Google Scholar 

  15. Vassilopoulou-Sellin R et al (1999) Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85(3):696–705

    Article  CAS  PubMed  Google Scholar 

  16. Li CI et al (2000) Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States). Cancer Causes Control 11(9):805–811

    Article  CAS  PubMed  Google Scholar 

  17. Chen AY et al (2001) The development of breast carcinoma in women with thyroid carcinoma. Cancer 92(2):225–231

    Article  CAS  PubMed  Google Scholar 

  18. Tanaka H et al (2001) Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res 92(1):1–8

    Article  CAS  PubMed  Google Scholar 

  19. Agrawal S, Eng C (2006) Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Hum Mol Genet 15(5):777–787

    Article  CAS  PubMed  Google Scholar 

  20. Ngeow J et al (2014) Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. J Clin Oncol 32(17):1818–1824

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Cybulski C et al (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75(6):1131–1135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yalavarthi S et al (2014) Metachronous malignancies in head and neck region: report of two cases. Indian J Pathol Microbiol 57(2):314–316

    Article  PubMed  Google Scholar 

  23. Park CM et al (2014) The prognosis and treatment of primary thyroid cancer occurred in breast cancer patients: comparison with ordinary thyroid cancer. Ann Surg Treat Res 86(4):169–176

    Article  PubMed  PubMed Central  Google Scholar 

  24. Castinetti F et al (2014) Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol 15(6):648–655

    Article  PubMed  Google Scholar 

  25. Hsu CH et al (2014) Co-occurrence of second primary malignancy in patients with thyroid cancer. QJM 107(8):643–648

    Article  CAS  PubMed  Google Scholar 

  26. Hall P et al (1991) Cancer risks in thyroid cancer patients. Br J Cancer 64(1):159–163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Canchola AJ, Horn-Ross PL, Purdie DM (2006) Risk of second primary malignancies in women with papillary thyroid cancer. Am J Epidemiol 163(6):521–527

    Article  PubMed  Google Scholar 

  28. Berthe E et al (2004) Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 31(5):685–691

    Article  PubMed  Google Scholar 

  29. Brown AP et al (2008) The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93(2):504–515

    Article  CAS  PubMed  Google Scholar 

  30. Sandeep TC et al (2006) Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab 91(5):1819–1825

    Article  CAS  PubMed  Google Scholar 

  31. Verkooijen RB et al (2006) The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer. Eur J Endocrinol 155(6):801–806

    Article  CAS  PubMed  Google Scholar 

  32. Hall P, Holm LE, Lundell G (1990) Second primary tumors following thyroid cancer. A Swedish record-linkage study. Acta Oncol 29(7):869–873

    Article  CAS  PubMed  Google Scholar 

  33. Johns ME et al (1986) Multiple primary neoplasms in patients with salivary gland or thyroid gland tumors. Laryngoscope 96(7):718–721

    Article  CAS  PubMed  Google Scholar 

  34. Rubino C et al (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89(9):1638–1644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kim C et al (2013) The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23(5):575–582

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lu CH et al (2013) Second primary malignancies following thyroid cancer: a population-based study in Taiwan. Eur J Endocrinol 169(5):577–585

    Article  CAS  PubMed  Google Scholar 

  37. Rubino C et al (2003) Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer 107(5):791–796

    Article  CAS  PubMed  Google Scholar 

  38. Sadetzki S et al (2003) Second primary breast and thyroid cancers (Israel). Cancer Causes Control 14(4):367–375

    Article  PubMed  Google Scholar 

  39. Consorti F et al (2011) Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer. World J Surg Oncol 9:88

    Article  PubMed  PubMed Central  Google Scholar 

  40. Schottenfeld D, Berg J (1971) Incidence of multiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst 46(1):161–170

    CAS  PubMed  Google Scholar 

  41. Evans HS et al (2001) Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 84(3):435–440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Schwartz A et al (1989) Racial and age differences in multiple primary cancers after breast cancer: a population-based analysis. Breast Cancer Res Treat 14(2):245–254

    Article  CAS  PubMed  Google Scholar 

  43. Schenker JG, Levinsky R, Ohel G (1984) Multiple primary malignant neoplasms in breast cancer patients in Israel. Cancer 54(1):139–144

    Article  Google Scholar 

  44. Beatson G (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases.1. Lancet 148(3802):104–107

    Article  Google Scholar 

  45. Subramanian S et al (2007) Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid 17(12):1277–1288

    Article  PubMed  Google Scholar 

  46. Sawka AM et al (2009) Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19(5):451–457

    Article  CAS  PubMed  Google Scholar 

  47. Levi F et al (1993) Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974–89. Br J Cancer 67(2):391–395

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Schenker JG, Levinsky R, Ohel G (1984) Multiple primary malignant neoplasms in breast cancer patients in Israel. Cancer 54(1):145–150

    Article  CAS  PubMed  Google Scholar 

  49. Longy M, Lacombe D (1996) Cowden disease. Report of a family and review. Ann Genet 39(1):35–42

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. The Whiteley-Martin Research Centre, The Discipline of Surgery, Sydney Medical School, Nepean Hospital, The University of Sydney, Clinical Building, Level 3, Penrith, NSW, 2751, Australia

    Kyle R. Joseph, Senarath Edirimanne & Guy D. Eslick

Authors
  1. Kyle R. Joseph
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Senarath Edirimanne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guy D. Eslick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guy D. Eslick.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joseph, K.R., Edirimanne, S. & Eslick, G.D. The association between breast cancer and thyroid cancer: a meta-analysis. Breast Cancer Res Treat 152, 173–181 (2015). https://doi.org/10.1007/s10549-015-3456-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-015-3456-6

Keywords

Search

Navigation